Status:
COMPLETED
Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
Asan Medical Center
Yonsei University
Conditions:
Diffuse Large B-cell Lymphoma
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study is to evaluate the incidence of central nervous system (CNS) relapse or metastasis in patients with diffuse large B-cell lymphoma.
Detailed Description
We dichotomize patients according to the risk of CNS involvement. Then, we perform CNS evaluation in patients at risk of CNS involvement. We prospectively monitor whether CNS relapse or metastasis occ...
Eligibility Criteria
Inclusion
- Newly diagnosed patients with diffuse large B cell lymphoma
- \> 20 years
- life expectancy more than 6 months
- Written informed consent
Exclusion
- Refusal to informed consent
- Lymphomas other than diffuse large B cell lymphoma
- Primary CNS lymphoma
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01202448
Start Date
August 1 2010
End Date
February 1 2015
Last Update
March 3 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135710
2
Asan Medical Center
Seoul, South Korea